Meet & hear from successful tech businesses owners, and understand how to build a start-up and bring it in various stages of development to Exit.

Speaker:

Tom Hayhurst, Managing Director Horizon Performance Consulting Group

Dr. Ingo Schroeter, CEO Econican , ex. Head of Strategy & Partnership at Philipps Healthcare & BCG Managing Partner

For 25 years Tom Hayhurst has been working closely with biotech start-up companies to advise founders, VC, and executive management on how to build the sales and marketing functions of a startup enterprise.

He has been consulting with executives from pre-IPO/startups to Fortune 500 companies in the healthcare industry. His scope of over 150 clients include device, lab services, point of care, and information management companies.

This first part of the course will cover 3 major topics

I. Opportunities US Investment Community Overview

• Investment landscape in the US market (Angel investment & Venture Capital)
• Overview of Biotech funding in the USA
• Top VC firms investing in Medtech & Biotech in USA

II. Challenges

• How to get the attention of investors in US market
• What investors are looking for, what are their criteria of investment
• What US-consumer market is looking for?
• How to map the US market
• Premarket research: What do you need to look for and why is it important?
• Disruptive vs replacement product
• High tech vs low tech
• Regulatory

III. How to Overcome the Challenges

• Describe the “problem” in the marketplace from your pre market research
• What is your “Idea” that would address that problem?
• What “product” or “service” have you created to address that problem?
• Who are your main competitors and why is your product superior?
• What “proof of concept” do you have to justify that it will work?
• Commodity or unique product/service?
• What “IP/Patent” protection do you have to preserve your idea/s?
• Has the “regulatory pathway” been defined?

Dr. Ingo Schroeter has close to three-decades of experience in Strategy Consulting and Management. Previous head of Strategy & Partnering in Philips Healthcare in Amsterdam, he was a member of most top governance groups of Philips. He managed the strategy, negotiation, and execution of Philips Partnerships with global Medtech and Health IT startups as well as pharmaceutical and molecular diagnostic companies.

He has worked for 15 years at the Boston Consulting Group primarily in technology practice (including medical technology) of which over 5 years as a partner and managing director. He supported the clients worldwide in more than 50 projects covering a broad range of topics including strategy, digitalization, platform economics, corporate development, due diligence and M&A, go to market and many more.

Dr. Schroeter will cover the following topics:

• Financial Valuation beyond DCF
• how to put a successful exit strategy for your start-up
• what is major driver for corporates in M&A or partnerships

Key Learnings

• How to successfully raise a VC fund in USA
• Financial Valuation of startup beyond DCF Method
• How to put a successful exit strategy for your start-up